查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1268931

2023-2030 年全球超声支气管内活检市场

Global Endobronchial Ultrasound Biopsy Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

全球超声支气管内活检市场预计将实现利润丰厚的增长，到 2022 年将达到 5.767 亿美元，到 2030 年将达到 8.327 亿美元。 在预测期内（2023 年至 2030 年），该市场的复合年增长率为 4.8%。 径向探头支气管内超声活检（RP-支气管内超声活检）和引导鞘（GS）为基础的活检技术经常用于周围肺部病变的诊断。

近年来，低温活检、电磁感应支气管镜、超薄支气管镜等技术相继出现，用于肺部疾病的精准诊断。 纵隔镜检查，纵隔淋巴结取样，比超声支气管内活检-TBNA 侵入性更小，也可用于肺门淋巴结取样，可作为轻度镇静的门诊手术进行。

超声支气管内活检市场在过去几年中取得了巨大的技术进步，创造了能够提供更准确、更快结果的新工具和方法。 这些发展使超声支气管内活检成为识别肺癌和其他呼吸系统疾病的首选方法。 由于超声活检无放射性且无痛，因此该市场有望实现高速增长。

超声支气管内活检市场的增长率正在增加对微创手术的需求，由于其具有与开放手术相比疼痛更小、恢復更快、并发症更少等诸多优点，因此呈现出高增长率各种因素。 超声支气管内活检的趋势是一种侵入性较小的手术，这使其成为患者和医疗保健专业人员的理想选择。 需要及早发现肺癌以改善患者预后并降低死亡率。

市场动态

不断上升的肺癌患病率和研发正在推动超声支气管内活检市场的增长。

随着肺癌患病率的上升，超声支气管内活检的全球市场正在扩大。 根据 2022 年肺癌状况报告，儘管 5 年生存率 (61%) 明显更高，但只有 26% 的肺癌病例被早期发现。 然而，44% 的病例发现得太晚，只有 7% 的病例存活下来。 烟草使用导致高达 90% 的肺癌发病率，长期使用烟草预计会增加全球癌症发病率，尤其是在中国、俄罗斯和印度等发展中国家。

主要参与者正在扩大对技术先进的产品（例如经支气管抽吸针）的研发工作。 这是由于对诊断工具的需求不断增长，以充分检测与肺部相关的感染和癌症。 目前，多家公司正在投资并做出重大努力，以开发更好的用于诊断目的的超声活检产品。

不断增加的医疗保健投资正在为製造商创造有利可图的增长前景。

由于超声支气管内活检在呼吸系统疾病诊断和肺部感染总体患病率方面的接受度越来越高，因此存在巨大的市场机会。 对诊断性经支气管穿刺针和活检钳等产品的需求将为製造商提供有利可图的增长选择。

冷冻活检、超薄膜支气管镜和电磁引导支气管镜等新技术刚刚出现，有助于准确检测肺部疾病。 超声支气管镜经支气管淋巴结抽吸 (TBNA) 也用于肺门淋巴结取样，可作为轻度镇静的门诊手术进行，但在纵隔内进行的纵隔镜检查侵入多于检查。 因此，增加对医疗保健基础设施的投资和支出有助于市场的增长。

超声支气管内活检费用高

支气管内活检非常昂贵，而且价格因地区、医疗机构和保险范围而异。 支气管内活检的费用可能令患者望而却步，尤其是在医疗费用较低的欠发达国家。

超声支气管内活检的费用可分为多项费用，包括使用的设备、治疗本身以及所需的善后护理。 根据您的医疗系统和国家/地区，您的保险可能会支付全部或部分治疗费用。

COVID-19 影响分析

COVID-19 分析包括 COVID 前情景、COVID 情景、COVID 后情景、价格动态（与 COVID 前情景相比，大流行期间和之后的价格变化）、供需范围（需求和供应变化由于贸易限制、封锁和随后的问题），政府举措（政府机构为振兴市场、部门和行业所做的努力）、製造商的战略举措（为缓解 COVID 问题製造商做了什么？）也进行了解释。

俄乌衝突分析

俄罗斯对乌克兰发动无法无天、毫无抵抗的全面入侵，美国和联合国对俄罗斯实施制裁。 由于危机，许多公司已开始暂停在俄罗斯的业务。 随着公司开始退出俄罗斯市场，制裁无疑将对全球市场产生重大影响。 由于金融监管恶化，俄乌战争将对俄罗斯医疗器械行业产生负面影响。

内容

第 1 章研究方法和范围

  • 调查方法
  • 调查目的和范围

第 2 章定义和概述

第 3 章执行摘要

  • 按产品类型分类的摘要
  • 按应用程序摘录
  • 最终用户的片段
  • 区域摘要

第四章市场动态

  • 影响因素
    • 司机
      • 超声支气管内活检设备的好处增加
      • 肺癌和研发增加
    • 约束因素
      • 超声支气管内活检费用高
    • 机会
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 价格分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 分析
    • 在 COVID-19 情景之前
    • 当前的 COVID-19 情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 结论

第 7 章按产品类型

  • 经支气管抽吸针
  • 活检针
  • 活检钳
  • 其他

第八章应用

  • 肺癌的诊断
  • 肺部感染的诊断

第 9 章最终用户

  • 医院
  • 诊断实验室
  • 癌症中心
  • 门诊手术中心
  • 学术和研究中心

第10章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
      • 其他亚太地区
  • 中东和非洲
    • 各地区的主要动态

第11章竞争格局

  • 竞争场景
  • 市场分析/份额分析
  • 併购分析

第12章公司简介

  • 奥林巴斯公司
    • 公司简介
    • 产品类型组合和说明
    • 财务摘要
    • 主要发展
  • Medtronic plc
  • CLINODEVICE
  • CONMED Corporation
  • Medi-Globe Corporation
  • Boston Scientific Corporation
  • Serpex Medical
  • Cook Group Incorporated
  • MICRO-TECH（Nanjing）Co., Ltd.
  • ACE Medical Devices Pvt. Ltd.

第13章 附录

简介目录
Product Code: MI4308

Market Overview

The global endobronchial ultrasound biopsy market reached US$ 576.7 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 832.7 million by 2030. The market is growing at a CAGR of 4.8% during the forecast period (2023-2030). To diagnose peripheral pulmonary lesions, radial probe endobronchial ultrasound biopsy (RP-endobronchial ultrasound biopsy ) and guide sheath (GS)-based biopsy methods are utilized frequently.

Cryo biopsy, electromagnetic navigational bronchoscopy, and ultrathin bronchoscopy have recently been developed to aid in the precise diagnosis of lung illnesses. The mediastinal LN sampling, mediastinoscopy, is less invasive than endobronchial ultrasound biopsy -TBNA, which can also be used to sample hilar lymph nodes and can be done as an outpatient procedure with light sedation.

In the endobronchial ultrasound biopsy market, over the past few years, technology has advanced drastically, with new tools and methods being created that give more precision and quicker outcomes. Because of these developments, endobronchial ultrasound biopsy is now the method of choice for identifying lung cancer and other respiratory conditions. The ultrasound biopsy market will see high growth as it doesn't use radiation and is painless.

The endobronchial ultrasound biopsy market growth rate is high owing to various factors such as increasing demand for minimally invasive procedures because they have a number of advantages over open surgeries, such as less pain, quicker recovery, and fewer complications. Endobronchial ultrasound biopsy trend is seen as it is a less invasive technique which makes it desirable for both patients and healthcare professionals. To improve patient outcomes and lower mortality rates, lung cancer must be detected early.

Market Dynamics

The increasing prevalence of lung cancer and research and development drives the growth of the endobronchial ultrasound biopsy market.

The global market for endobronchial ultrasound biopsy is expanding as a result of the rising prevalence of lung cancer. Only 26% of lung cancer cases are identified at an early stage, despite the fact that the five-year survival rate is substantially higher (61%), according to the State of Lung Cancer 2022 Report. However, 44% of cases are discovered far too late, when just 7% of them survive. Up to 90% of occurrences of lung cancer are attributable to tobacco use, and prolonged usage is expected to increase the incidence of cancer worldwide, especially in developing countries like China, Russia, and India.

Key players are expanding their research and development efforts for technologically advanced products such as transbronchial aspiration needles. This is happening as a result of the rising demand for diagnostic tools for proper detection of lung related infections or cancer. Several firms are currently investing and putting a lot of effort in developing better ultrasound biopsy products for diagnostic purposes.

The growing investments in healthcare create lucrative growth prospects for manufacturers.

There is a sizable market opportunity for endobronchial ultrasound biopsy as it is becoming more widely accepted for the diagnosis of respiratory disorders and because the overall prevalence of lung infections is rising. Manufacturers are going to have profitable choices for growth as demand for products like transbronchial aspiration needles or biopsy forceps for diagnosis will be required.

To assist in the accurate detection of lung diseases, new technologies such as cryo biopsy, ultrathin bronchoscopy, and electromagnetic navigational bronchoscopy were just recently created. The endobronchial ultrasonography biopsy, or TBNA, which may be utilized as well for sampling hilar lymph nodes & can be performed as an outpatient operation with mild sedation, is more intrusive than mediastinoscopy, which takes place inside the mediastinum. Hence, rising investments or healthcare infrastructure spending are contributing to the growth of the market.

High cost of an endobronchial ultrasound biopsy

An endobronchial ultrasound biopsy can be expensive, and the price can change depending on the area, the medical center, and insurance coverage. In some circumstances, patients may find the expense of an endobronchial ultrasound biopsy to be exorbitant, especially in underdeveloped nations where healthcare spending is minimal.

The price of an endobronchial ultrasound biopsy procedure can be broken down into a number of different costs, including those for the tools used, the treatment itself, and any required aftercare. Depending on the health plan and the nation, insurance may occasionally pay all or part of the cost of the treatment.

COVID-19 Impact Analysis

The COVID-19 analysis includes Pre-COVID Scenario, COVID Scenario and Post-COVID Scenario along with pricing dynamics (including pricing change during and post-pandemic comparing it with pre-COVID scenarios), demand-supply spectrum (shift in demand and supply owing to trading restrictions, lockdown and subsequent issues), government initiatives (initiatives to revive market, sector or industry by government bodies) and manufacturers strategic initiatives (what manufacturers did to mitigate the COVID issues will be covered here).

Russia Ukraine Conflict Analysis

Russia started its unlawful and unprovoked full-scale invasion of Ukraine, which resulted in sanctions against Russia from the US, the UN, and other nations. In light of the current crisis, many businesses are starting to stop operating in Russia. These sanctions will surely have a significant effect on the worldwide market as businesses start to leave the Russian market. Due to worsening financial restrictions, the Russo-Ukrainian War will have a detrimental effect on the medical device industry in Russia.

Segment Analysis

The global endobronchial ultrasound biopsy market is segmented based on product type, application, End User and region.

Lung cancer diagnosis segment holds largest 63.7% of market share owing to the rising incidence of lung cancers

Lung cancer diagnosis segment will dominate the global endobronchial ultrasound biopsy market over the forecast period, owing to the rise in patients with lung cancer. Lung cancer, infections, and other disorders affecting enlarged lymph nodes in the chest can all be identified with endobronchial ultrasonography (EBUS), a minimally invasive but extremely efficient method.

EBUS enables doctors to use a method known as transbronchial needle aspiration (TBNA) to retrieve tissue or fluid samples from the lungs and adjacent lymph nodes without requiring traditional surgery. The samples can be used to identify tumours like lymphoma, diagnose and stage lung cancer, find infections, and diagnose inflammatory diseases that damage the lungs, such as sarcoidosis.

For instance, Olympus offers 19G EBUS-TBNA needles in addition to the 21G, 22G, and 25G needles, which is unmatched in the industry. The business also offers the ViziShot2 FLEX 19G, a second-generation EBUS needle that assists with histology sampling for suspected cases of lymphoma and sarcoidosis while also supplying more tissue for cutting-edge molecular analysis that enables targeted lung cancer treatment.

Geographical Analysis

North America holds 39.8% of market share owing to the strong presence of major players and increasing healthcare infrastructure investment.

Manufacturers have chances to expand their operations in this region because of the rising demand for diagnostic tools for lung infections in North America. The area has many producers and suppliers, and its rapid economic development has raised industrial production of endobronchial ultrasound biopsy, which has increased the demand.

Growth is also fueled by government measures to promote technologically advanced biopsy tools. Another issue is the rapidly expanding population with lung cancer, which has increased demand for cutting-edge, diagnostic and treatment tools. The region is growing as healthcare professionals have good knowledge about the endobronchial ultrasound biopsy tool, and they are adopting it highly for diagnosis of lung related issues among people.

Competitive Landscape

The major global players in the endobronchial ultrasound biopsy market include Olympus Corporation, CLINODEVICE, Medtronic, CONMED Corporation, Boston Scientific Corporation, Medi-Globe GmbH, Serpex Medical, MICRO-TECH (Nanjing) Co., Ltd., Cook Group Incorporated, and ACE Medical Devices Pvt. Ltd. among others.

Why Purchase the Report?

  • To visualize the global endobronchial ultrasound biopsy market segmentation based on product type, application, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of endobronchial ultrasound biopsy market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global endobronchial ultrasound biopsy market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing benefits of endobronchial ultrasound biopsy devices
      • 4.1.1.2. Increasing prevalence of lung cancer and research and development
    • 4.1.2. Restraints
      • 4.1.2.1. High cost of an endobronchial ultrasound biopsy
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Before COVID-19 Scenario
    • 6.1.2. Present COVID-19 Scenario
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Transbronchial Aspiration Needles *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Biopsy Needles
  • 7.4. Biopsy Forceps
  • 7.5. Other

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Lung Cancer Diagnosis *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Lung Infection Diagnosis

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Diagnostics Laboratories
  • 9.4. Cancer Specialty Centers
  • 9.5. Ambulatory Surgical Centers
  • 9.6. Academic and Research centers

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan

Australia

      • 10.5.6.4. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Olympus Corporation *
    • 12.1.1. Company Overview
    • 12.1.2. Product Type Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Medtronic plc
  • 12.3. CLINODEVICE
  • 12.4. CONMED Corporation
  • 12.5. Medi-Globe Corporation
  • 12.6. Boston Scientific Corporation
  • 12.7. Serpex Medical
  • 12.8. Cook Group Incorporated
  • 12.9. MICRO-TECH (Nanjing) Co., Ltd.
  • 12.10. ACE Medical Devices Pvt. Ltd.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us